South & Central America Bioanalytical Testing Services Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]

No. of Pages: 100    |    Report Code: BMIRE00029566    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Bioanalytical Testing Services Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Bioanalytical Testing Services Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Bioanalytical Testing Services Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
  • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
5.2 Market Opportunities
  • 5.2.1 Uninterrupted Growth of Pharmaceuticals Industry
5.3 Future Trends
  • 5.3.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
5.4 Impact of Drivers and Restraints

6. South & Central America Bioanalytical Testing Services Market Regional Analysis

6.1 South & Central America Bioanalytical Testing Services Market Overview
6.2 South & Central America Bioanalytical Testing Services Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Bioanalytical Testing Services Market Forecast Analysis

7. South & Central America Bioanalytical Testing Services Market Analysis – by Services

7.1 Pharmacokinetics
  • 7.1.1 Overview
  • 7.1.2 Pharmacokinetics: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Biomarkers
  • 7.2.1 Overview
  • 7.2.2 Biomarkers: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Immunogenicity
  • 7.3.1 Overview
  • 7.3.2 Immunogenicity: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Virology Testing
  • 7.4.1 Overview
  • 7.4.2 Virology Testing: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Cell-based assays
  • 7.5.1 Overview
  • 7.5.2 Cell-based assays: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Bioanalytical Testing Services Market Analysis – by Disease Indication

8.1 Cardiovascular
  • 8.1.1 Overview
  • 8.1.2 Cardiovascular: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Neurological Disorders
  • 8.2.1 Overview
  • 8.2.2 Neurological Disorders: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Metabolic Disorders
  • 8.3.1 Overview
  • 8.3.2 Metabolic Disorders: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Autoimmune Disorders
  • 8.4.1 Overview
  • 8.4.2 Autoimmune Disorders: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Respiratory Diseases
  • 8.5.1 Overview
  • 8.5.2 Respiratory Diseases: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Oncology
  • 8.6.1 Overview
  • 8.6.2 Oncology: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Sexual Health
  • 8.7.1 Overview
  • 8.7.2 Sexual Health: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Bone Disease
  • 8.8.1 Overview
  • 8.8.2 Bone Disease: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Bioanalytical Testing Services Market Analysis – by End User

9.1 Pharmaceutical and Biopharmaceutical Companies
  • 9.1.1 Overview
  • 9.1.2 Bone Disease: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Contract Research Organization
  • 9.2.1 Overview
  • 9.2.2 Bone Disease: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Contract Development And Manufacturing Organization
  • 9.3.1 Overview
  • 9.3.2 Bone Disease: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Bioanalytical Testing Services Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Bioanalytical Testing Services Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 South & Central America Bioanalytical Testing Services Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Bioanalytical Testing Services Market Breakdown, by Services
    • 10.1.1.1.2 Brazil: South & Central America Bioanalytical Testing Services Market Breakdown, by Disease Indication
    • 10.1.1.1.3 Brazil: South & Central America Bioanalytical Testing Services Market Breakdown, by End User
  • 10.1.1.2 Argentina: South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Bioanalytical Testing Services Market Breakdown, by Services
    • 10.1.1.2.2 Argentina: South & Central America Bioanalytical Testing Services Market Breakdown, by Disease Indication
    • 10.1.1.2.3 Argentina: South & Central America Bioanalytical Testing Services Market Breakdown, by End User
  • 10.1.1.3 Rest of South and Central America : South & Central America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Bioanalytical Testing Services Market Breakdown, by Services
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Bioanalytical Testing Services Market Breakdown, by Disease Indication
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Bioanalytical Testing Services Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Bioanalytical Testing Services Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 SGS SA
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Pharmaron Beijing Co Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Element Materials Technology Group Ltd
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Charles River Laboratories International Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Eurofins Scientific SE
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Labcorp Drug Development Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Syneos Health Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 ICON Plc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Intertek Group Plc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - South & Central America Bioanalytical Testing Services Market

1. SGS SA

2. Pharmaron Beijing Co Ltd

3. Element Materials Technology Group Ltd

4. Charles River Laboratories International Inc

5. Eurofins Scientific SE

6. Labcorp Drug Development Inc

7. Syneos Health Inc

8. ICON Plc

9. Intertek Group Plc

south-and-central-america-bioanalytical-testing-services-market